Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Chen

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
International Journal of Women'S Dermatology|July 5, 2021
Medical student perceptions of assessment systems, subjectivity, and variability on introductory dermatology clerkshipsJaewon Yoon, Jordan T Said, Leah L Thompson, et al.
International Journal of Dermatology|January 11, 2023
Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reactionConnie R Shi, Michael Shaughnessy, Kartik Sehgal, et al.
Journal of the American Academy of Dermatology|October 20, 2020
Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitorsLeah L Thompson, Catherina X Pan, Michael S Chang, et al.
Archives of Dermatological Research|August 17, 2024
Impact of insurance status on treatment choice and hospitalization rates in bullous pemphigoid patients: a retrospective cross-sectional analysisDavid H Xiang, Allison Holt, Beatrix B Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2021
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoidConnie R Shi, Tracey S Otto, Leah L Thompson, et al.
Journal of the American Academy of Dermatology|November 29, 2020
Cutaneous adverse events to immune checkpoint inhibitors in pediatric populations: A retrospective cohort studyLindsay McCormack, Leah L Thompson, Michael S Chang, et al.
Journal of the American Academy of Dermatology|September 28, 2019
Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: A retrospective cohort studySteven T Chen, Gabriel E Molina, Jennifer A Lo, et al.
Journal of the American Academy of Dermatology|May 14, 2026
False negative rate of direct immunofluorescence in bullous pemphigoid does not significantly differ by anatomic siteBeatrix B Thompson, Rachel M Reardon, Claire Lin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 15, 2026
Pre-existing psoriasis and immune-related adverse events following immunotherapy for lung cancerSydney Corey, Natalie Braun, Beatrix B Thompson, et al.
Pediatric Blood & Cancer|August 17, 2020
Discordance between recommended and delivered therapies for immunotherapy-associated cutaneous toxicities in pediatric populationsLeah L Thompson, Michael S Chang, Lindsay McCormack, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
International Journal of Women'S Dermatology|July 5, 2021
Medical student perceptions of assessment systems, subjectivity, and variability on introductory dermatology clerkshipsJaewon Yoon, Jordan T Said, Leah L Thompson, et al.
International Journal of Dermatology|January 11, 2023
Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reactionConnie R Shi, Michael Shaughnessy, Kartik Sehgal, et al.
Journal of the American Academy of Dermatology|October 20, 2020
Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitorsLeah L Thompson, Catherina X Pan, Michael S Chang, et al.
Archives of Dermatological Research|August 17, 2024
Impact of insurance status on treatment choice and hospitalization rates in bullous pemphigoid patients: a retrospective cross-sectional analysisDavid H Xiang, Allison Holt, Beatrix B Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2021
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoidConnie R Shi, Tracey S Otto, Leah L Thompson, et al.
Journal of the American Academy of Dermatology|November 29, 2020
Cutaneous adverse events to immune checkpoint inhibitors in pediatric populations: A retrospective cohort studyLindsay McCormack, Leah L Thompson, Michael S Chang, et al.
Journal of the American Academy of Dermatology|September 28, 2019
Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: A retrospective cohort studySteven T Chen, Gabriel E Molina, Jennifer A Lo, et al.
Journal of the American Academy of Dermatology|May 14, 2026
False negative rate of direct immunofluorescence in bullous pemphigoid does not significantly differ by anatomic siteBeatrix B Thompson, Rachel M Reardon, Claire Lin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 15, 2026
Pre-existing psoriasis and immune-related adverse events following immunotherapy for lung cancerSydney Corey, Natalie Braun, Beatrix B Thompson, et al.
Pediatric Blood & Cancer|August 17, 2020
Discordance between recommended and delivered therapies for immunotherapy-associated cutaneous toxicities in pediatric populationsLeah L Thompson, Michael S Chang, Lindsay McCormack, et al.
Pageof 16